The antibody discovery market is expanding, driven by the increasing incidence of chronic conditions such as cancer, diabetes, and cardiovascular and ...

BioNTech SE and Pfizer (PFE) recently received a positive recommendation from the European Medicines Agency for marketing ...

The appointment of a seasoned pharmaceutical executive, George Tidmarsh, to run the FDA’s drug center underscores the ...

Pfizer (PFE) is currently under significant scrutiny due to a study linking its product, Depo-Provera, to increased health risks, and an associated Multi-District Litigation could have influenced its ...

The rising occurrence of dysmenorrhea, along with greater awareness and advancements in diagnosis, is driving substantial growth in the dysmenorrhea ...

The Canadian Patent Office has a procedure for the “re-examination” of a granted patent. However, this procedure is rarely used in Canada for several reasons. Less than half a dozen re-examinations ...

President Donald Trump is readying plans for industry-specific tariffs to kick in alongside his country-by-country duties in two weeks, ramping up his push to reshape the United States' ...

The global bone and joint health supplements market size was US$ 2.1 billion in 2021. The global bone and joint health supplements market is expected to grow to US$ 3.5 billion by 2030 by registering ...

The global animal biotechnology market size was US$ 21.1 billion in 2021. The global animal biotechnology market is expected to grow to US$ 45.1 billion by 2030 by registering a compound annual growth ...

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...

Johnson & Johnson JNJ and Pfizer PFE rank among the world’s largest pharmaceutical companies, each with broad and diversified healthcare portfolios. J&J operates primarily through its pharmaceuticals ...

Key considerations for discovery in AI-focused intellectual property (IP) litigation, including an examination of a ...